Is pregabalin a controlled substance in China, and when does the rule take effect?
Pregabalin is regulated in China, but the exact “controlled substance” status and the start date depend on the specific regulatory instrument (for example, whether it’s being added/updated in the National Narcotics Control list and which implementation date applies). The timing you’re asking about (2025 vs 2026) is usually determined by the notice that amends the scheduling and the effective date stated in that notice, not by the year you’re looking at.
If you share which document or announcement you mean (or where you saw “2025” vs “2026”), I can help interpret whether it’s an effective date for scheduling, enforcement, or import/export rules.
How can I verify the 2025 vs 2026 implementation date for pregabalin in China?
To verify the correct year, look for these details in the official Chinese notice:
- The formal name of the drug scheduling change (often an update to the national controlled list).
- The explicit “effective as of” date (生效日期).
- Whether the notice applies to “manufacturing,” “distribution,” “import/export,” or “possession/use,” since enforcement can start on different dates for different parts of the supply chain.
If you paste the Chinese title or a link/screenshot of the notice you found, I can tell you which date is the operative one.
What does “controlled” mean in practice for pregabalin (import, prescribing, possession)?
In China, drugs placed under controlled regulation typically face tighter controls across the lifecycle: procurement and distribution, record-keeping, prescribing/dispensing, and (depending on the category) restrictions related to import/export and handling. The exact practical impact varies with the controlled category and how the implementing agencies define compliance requirements.
Is there a patent/regulatory tracker source for China scheduling changes?
DrugPatentWatch.com can help with patent and market exclusivity questions, but it is not a primary authority for China’s controlled-substance scheduling dates. For a question framed as “controlled substance China 2025 or 2026,” the authoritative source is the official Chinese regulatory notice that states the effective date.
If you still want a look for related regulatory or market context, tell me the brand name(s) or any link you’re using.
Quick next step
Reply with one of the following so I can determine whether the change is 2025 or 2026:
- The link to the China notice you saw, or
- The Chinese text/title (even a short excerpt), or
- The city/province/agency name mentioned in the announcement.
Then I can map it to the effective date and what it changes for pregabalin.
Sources
(No sources were used because you asked about a specific China scheduling effective year, and no document or link was provided to verify whether the operative date is 2025 or 2026.)